The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

Tomi Akinyemiju(University of Alabama at Birmingham), Semaw Ferede Abera(University of Hohenheim), Muktar Beshir Ahmed(Jimma University), Noore Alam(The University of Queensland), Mulubirhan Assefa Alemayohu(Mekelle University), Christine A. Allen(University of Washington), Rajaa Al‐Raddadi(Ministry of Health), Nelson Alvis‐Guzmán(University of Cartagena), Yaw Ampem Amoako(Komfo Anokye Teaching Hospital), Al Artaman(University of Manitoba), Tadesse Awoke Ayele(University of Gondar), Aleksandra Barać(Center for Health, Exercise and Sport Sciences), Isabela M. Benseñor(Hospital Universitário da Universidade de São Paulo), Adugnaw Berhane(Debre Berhan University), Zulfiqar A Bhutta(Aga Khan University), Jacqueline Castillo-Rivas(Costa Rican Department of Social Security), Abdulaal Chitheer(Ministry of Health), Jee-Young Jasmine Choi(Seoul National University), Benjamin Cowie(Peter Doherty Institute), Lalit Dandona(University of Washington), Rakhi Dandona(University of Washington), Subhojit Dey(Indian Institute of Public Health Gandhinagar), Daniel Dicker(University of Washington), Huyen Phuc(Duy Tan University), Donatus U. Ekwueme(Centers for Disease Control and Prevention), Maysaa El Sayed Zaki(Mansoura University), Florian Fischer(Bielefeld University), Thomas Fürst(Swiss Tropical and Public Health Institute), Jamie Hancock(University of Washington), Simon I Hay(University of Washington), Peter J. Hotez(Baylor College of Medicine), Sun Ha Jee(Yonsei University), Amir Kasaeian(Tehran University of Medical Sciences), Yousef Khader(Jordan University of Science and Technology), Young‐Ho Khang(Seoul National University), G Anil Kumar(Public Health Foundation of India), Michael Kutz(University of Washington), Heidi J. Larson(London School of Hygiene & Tropical Medicine), Alan D Lopez(The University of Melbourne), Raimundas Lunevičius(University of Liverpool), Reza Malekzadeh(Tehran University of Medical Sciences), Colm McAlinden(Bristol Hospital), Toni Meier(Martin Luther University Halle-Wittenberg), Walter Mendoza, Ali H. Mokdad(University of Washington), Maziar Moradi‐Lakeh(Iran University of Medical Sciences), Gabriele Nagel(Universität Ulm), Quyen Le Nguyen(Duy Tan University), Grant Nguyen(University of Washington), Felix Akpojene Ogbo(Ingham Institute), George Patton(The University of Melbourne), David M. Pereira(Universidade do Porto), Farshad Pourmalek(University of British Columbia), Mostafa Qorbani(Jahrom University of Medical Sciences), Amir Radfar(A.T. Still University), Gholamreza Roshandel(Golestan University), Joshua A. Salomon(Harvard Global Health Institute), Juan Sanabria(Case Western Reserve University), Benn Sartorius(University of KwaZulu-Natal), Maheswar Satpathy(All India Institute of Medical Sciences), Monika Sawhney(Marshall University), Sadaf G Sepanlou(Tehran University of Medical Sciences), Katya Anne Shackelford(University of Washington), Hirbo Shore Roba(Haramaya University), Jiandong Sun(Queensland University of Technology), Desalegn Tadese Mengistu(Mekelle University), Roman Topór-Mądry(Jagiellonian University), Bach Xuan Tran(Johns Hopkins University), Kingsley Nnanna Ukwaja(Federal Teaching Hospital Abakaliki), Vasily Vlassov(National Research University Higher School of Economics), Stein Emil Vollset(Norwegian Institute of Public Health), Theo Vos(University of Washington), Tolassa Wakayo(Jimma University), Elisabete Weiderpass(Karolinska Institutet), Andrea Werdecker(Federal Institute for Population Research), Naohiro Yonemoto(Kyoto University), Mustafa Z Younis(Harvard University), Chuanhua Yu(Wuhan University), Zoubida Zaidi(University Ferhat Abbas of Setif), Liguo Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Christopher J L Murray(University of Washington), Mohsen Naghavi(University of Washington), Christina Fitzmaurice(University of Washington)
JAMA Oncology
October 5, 2017
Cited by 2,011Open Access
Full Text

Abstract

<h3>Importance</h3> Liver cancer is among the leading causes of cancer deaths globally. The most common causes for liver cancer include hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and alcohol use. <h3>Objective</h3> To report results of the Global Burden of Disease (GBD) 2015 study on primary liver cancer incidence, mortality, and disability-adjusted life-years (DALYs) for 195 countries or territories from 1990 to 2015, and present global, regional, and national estimates on the burden of liver cancer attributable to HBV, HCV, alcohol, and an “other” group that encompasses residual causes. <h3>Design, Settings, and Participants</h3> Mortality was estimated using vital registration and cancer registry data in an ensemble modeling approach. Single-cause mortality estimates were adjusted for all-cause mortality. Incidence was derived from mortality estimates and the mortality-to-incidence ratio. Through a systematic literature review, data on the proportions of liver cancer due to HBV, HCV, alcohol, and other causes were identified. Years of life lost were calculated by multiplying each death by a standard life expectancy. Prevalence was estimated using mortality-to-incidence ratio as surrogate for survival. Total prevalence was divided into 4 sequelae that were multiplied by disability weights to derive years lived with disability (YLDs). DALYs were the sum of years of life lost and YLDs. <h3>Main Outcomes and Measures</h3> Liver cancer mortality, incidence, YLDs, years of life lost, DALYs by etiology, age, sex, country, and year. <h3>Results</h3> There were 854 000 incident cases of liver cancer and 810 000 deaths globally in 2015, contributing to 20 578 000 DALYs. Cases of incident liver cancer increased by 75% between 1990 and 2015, of which 47% can be explained by changing population age structures, 35% by population growth, and −8% to changing age-specific incidence rates. The male-to-female ratio for age-standardized liver cancer mortality was 2.8. Globally, HBV accounted for 265 000 liver cancer deaths (33%), alcohol for 245 000 (30%), HCV for 167 000 (21%), and other causes for 133 000 (16%) deaths, with substantial variation between countries in the underlying etiologies. <h3>Conclusions and Relevance</h3> Liver cancer is among the leading causes of cancer deaths in many countries. Causes of liver cancer differ widely among populations. Our results show that most cases of liver cancer can be prevented through vaccination, antiviral treatment, safe blood transfusion and injection practices, as well as interventions to reduce excessive alcohol use. In line with the Sustainable Development Goals, the identification and elimination of risk factors for liver cancer will be required to achieve a sustained reduction in liver cancer burden. The GBD study can be used to guide these prevention efforts.


Related Papers

No related papers found

Powered by citation graph analysis